Wellman Paul J, Davis Kristina W, Clifford P Shane, Rothman Richard B, Blough Bruce E
Behavioral Neuroscience Program, Department of Psychology, Texas A&M University, College Station, TX 77843-4235, USA.
Drug Alcohol Depend. 2009 Mar 1;100(3):234-9. doi: 10.1016/j.drugalcdep.2008.10.005. Epub 2008 Dec 4.
Studies of the biobehavioral actions of psychostimulants commonly focus on locomotion and less commonly on feeding, and only rarely are these measures considered in conjunction within the same animal. The present study compared the impact of (+)-amphetamine and three amphetamine analogs, PAL-287, PAL-313, and PAL-353, on eating and locomotion assessed concurrently using an automated activity/feeding chamber during a daily 45 min session. Each analog is a potent releaser of norepinephrine and of dopamine, but exerts differential serotonin-releasing activity (PAL-287>PAL-313>amphetamine>PAL-353). Rats were tested with each of five doses of drug (0, 2, 4, 8, or 16 micromol/kg, i.p.), given in equimolar concentrations and in random dose order. PAL-353, an analog with minimal serotonin-releasing capacity, markedly stimulated forward locomotion at 2, 4, 8 and 16 micromol/kg, as did amphetamine, whereas PAL-287 and PAL-313 did not. In contrast to the locomotor findings, all four amphetamine-like drugs exerted similar effects on the suppression of food intake. These results suggest that the capacity of an amphetamine analog (i.e. amphetamine and PAL-353) to stimulate serotonin release can diminish its psychostimulant action on locomotion, but does not reliably augment drug-induced hypophagia.
对精神兴奋剂生物行为作用的研究通常集中于运动,而较少关注进食,并且在同一动物体内同时考虑这些指标的情况极为罕见。本研究比较了(+)-苯丙胺和三种苯丙胺类似物PAL-287、PAL-313和PAL-353对进食和运动的影响,在每日45分钟的实验过程中使用自动活动/进食箱同时进行评估。每种类似物都是去甲肾上腺素和多巴胺的强效释放剂,但具有不同的5-羟色胺释放活性(PAL-287>PAL-313>苯丙胺>PAL-353)。用五种剂量的药物(0、2、4、8或16微摩尔/千克,腹腔注射)对大鼠进行测试,药物以等摩尔浓度且随机剂量顺序给药。PAL-353是一种5-羟色胺释放能力最小的类似物,在2、4、8和16微摩尔/千克时显著刺激向前运动,苯丙胺也是如此,而PAL-287和PAL-313则不然。与运动结果相反,所有四种苯丙胺样药物对食物摄入的抑制作用相似。这些结果表明,苯丙胺类似物(即苯丙胺和PAL-353)刺激5-羟色胺释放的能力可减弱其对运动的精神兴奋作用,但不能可靠地增强药物诱导的摄食减少。